SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001016169-08-000021
Filing Date
2008-04-01
Accepted
2008-04-01 16:38:56
Documents
4
Period of Report
2007-12-31
Effectiveness Date
2008-04-01

Document Format Files

Seq Description Document Type Size
1 march2008proxydef.htm DEF 14A 1284807
2 GRAPHIC img1.jpg GRAPHIC 1173
3 GRAPHIC img2.gif GRAPHIC 6030
4 GRAPHIC img3.jpg GRAPHIC 1717
  Complete submission text file 0001016169-08-000021.txt   1299248
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA INC (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32302 | Film No.: 08729870
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10